Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management

The advent of immunotherapy, specifically of immune checkpoint inhibitors (ICIs), for the treatment of solid tumors has deeply transformed therapeutic algorithms in medical oncology. Approximately one-third of patients treated with ICIs may de velop immune-related adverse events, and the gastrointes...

Descripción completa

Detalles Bibliográficos
Autores principales: Terrin, Maria, Migliorisi, Giulia, Dal Buono, Arianna, Gabbiadini, Roberto, Mastrorocco, Elisabetta, Quadarella, Alessandro, Repici, Alessandro, Santoro, Armando, Armuzzi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380448/
https://www.ncbi.nlm.nih.gov/pubmed/37511260
http://dx.doi.org/10.3390/ijms241411504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380448/
https://www.ncbi.nlm.nih.gov/pubmed/37511260
http://dx.doi.org/10.3390/ijms241411504

Ejemplares similares